Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2001 1
2002 37
2003 37
2004 30
2005 29
2006 27
2007 28
2008 11
2009 17
2010 17
2011 13
2012 10
2013 11
2014 9
2015 11
2016 2
2017 6
2018 11
2019 7
2020 10
2021 13
2022 11
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Results by year

Filters applied: . Clear all
Page 1
Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease.
Tanaka A, Maeda S, Nomura T, Llamas-Covarrubias MA, Tanaka S, Jin L, Lim EL, Morikawa H, Kitagawa Y, Akizuki S, Ito Y, Fujimori C, Hirota K, Murase T, Hashimoto M, Higo J, Zamoyska R, Ueda R, Standley DM, Sakaguchi N, Sakaguchi S. Tanaka A, et al. Among authors: ueda r. J Exp Med. 2023 Feb 6;220(2):e20220386. doi: 10.1084/jem.20220386. Epub 2022 Dec 1. J Exp Med. 2023. PMID: 36454183 Free PMC article.
Current status of immunotherapy.
Suzuki S, Ishida T, Yoshikawa K, Ueda R. Suzuki S, et al. Among authors: ueda r. Jpn J Clin Oncol. 2016 Mar;46(3):191-203. doi: 10.1093/jjco/hyv201. Epub 2016 Jan 26. Jpn J Clin Oncol. 2016. PMID: 26819277 Review.
Clinical landscape of TP73 structural variants in ATL patients.
Hiramatsu H, Yokomori R, Shengyi L, Tanaka N, Mori S, Kiyotani K, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Sanda T, Ishida T. Hiramatsu H, et al. Among authors: ueda r. Leukemia. 2023 Dec;37(12):2502-2506. doi: 10.1038/s41375-023-02059-9. Epub 2023 Oct 20. Leukemia. 2023. PMID: 37864123 Free PMC article. No abstract available.
Immunopathogenesis of lymphoma: focus on CCR4.
Ishida T, Ueda R. Ishida T, et al. Among authors: ueda r. Cancer Sci. 2011 Jan;102(1):44-50. doi: 10.1111/j.1349-7006.2010.01767.x. Epub 2010 Nov 2. Cancer Sci. 2011. PMID: 21044233 Free article. Review.
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.
Fujikawa K, Saito T, Kurose K, Kojima T, Funakoshi T, Sato E, Kakimi K, Iida S, Doki Y, Oka M, Ueda R, Wada H. Fujikawa K, et al. Among authors: ueda r. PLoS One. 2023 Sep 20;18(9):e0291772. doi: 10.1371/journal.pone.0291772. eCollection 2023. PLoS One. 2023. PMID: 37729184 Free PMC article. Clinical Trial.
328 results